| Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients A Scarpa, W Mantovani, P Capelli, S Beghelli, L Boninsegna, R Bettini, ... Modern Pathology 23 (6), 824-833, 2010 | 539 | 2010 |
| Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization F Panzuto, S Nasoni, M Falconi, VD Corleto, G Capurso, S Cassetta, ... Endocrine-related cancer 12 (4), 1083-1092, 2005 | 479 | 2005 |
| Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression F Panzuto, L Boninsegna, N Fazio, D Campana, M Pia Brizzi, G Capurso, ... Journal of Clinical Oncology 29 (17), 2372-2377, 2011 | 327 | 2011 |
| Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours R Bettini, L Boninsegna, W Mantovani, P Capelli, C Bassi, P Pederzoli, ... Annals of Oncology 19 (5), 903-908, 2008 | 257 | 2008 |
| Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma F Panzuto, M Di Fonzo, E Iannicelli, R Sciuto, CL Maini, G Capurso, ... Annals of Oncology 17 (3), 461-466, 2006 | 190 | 2006 |
| Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections L Boninsegna, F Panzuto, S Partelli, P Capelli, G Delle Fave, R Bettini, ... European Journal of Cancer 48 (11), 1608-1615, 2012 | 189 | 2012 |
| Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study A Larghi, G Capurso, A Carnuccio, R Ricci, S Alfieri, D Galasso, F Lugli, ... Gastrointestinal endoscopy 76 (3), 570-577, 2012 | 185 | 2012 |
| Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate E Merola, A Sbrozzi-Vanni, F Panzuto, G D’Ambra, E Di Giulio, E Pilozzi, ... Neuroendocrinology 95 (3), 207-213, 2012 | 166 | 2012 |
| Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors F Panzuto, C Severi, R Cannizzaro, M Falconi, S Angeletti, A Pasquali, ... Journal of endocrinological investigation 27, 6-11, 2004 | 159 | 2004 |
| Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets G Capurso, S Lattimore, T Crnogorac-Jurcevic, F Panzuto, M Milione, ... Endocrine-related cancer 13 (2), 541-558, 2006 | 119 | 2006 |
| Endocrine tumours of the stomach G Delle Fave, G Capurso, M Milione, F Panzuto Best practice & research Clinical gastroenterology 19 (5), 659-673, 2005 | 117 | 2005 |
| Prognosis of sporadic resected small (≤ 2 cm) nonfunctional pancreatic neuroendocrine tumors–a multi-institutional study VJ Sallinen, TYS Le Large, E Tieftrunk, S Galeev, Z Kovalenko, ... HPB 20 (3), 251-259, 2018 | 116 | 2018 |
| Real-world study of everolimus in advanced progressive neuroendocrine tumors F Panzuto, M Rinzivillo, N Fazio, F de Braud, G Luppi, MC Zatelli, F Lugli, ... The oncologist 19 (9), 966-974, 2014 | 109 | 2014 |
| Molecular pathology and genetics of pancreatic endocrine tumours. G Capurso, S Festa, R Valente, M Piciucchi, F Panzuto, RT Jensen, ... Journal of molecular endocrinology 49 (1), R37-50, 2012 | 107 | 2012 |
| Large hiatal hernia in patients with iron deficiency anaemia: a prospective study on prevalence and treatment F Panzuto, E Di Giulio, G Capurso, F Baccini, G D'Ambra, G Delle Fave, ... Alimentary pharmacology & therapeutics 19 (6), 663-670, 2004 | 98 | 2004 |
| Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: data from a large international cohort study G Rindi, C Klersy, L Albarello, E Baudin, A Bianchi, MW Buchler, M Caplin, ... Neuroendocrinology 107 (4), 375-386, 2019 | 93 | 2019 |
| SARS-CoV2 RNA detection in a pancreatic pseudocyst sample T Schepis, A Larghi, A Papa, L Miele, F Panzuto, L De Biase, B Annibale, ... Pancreatology 20 (5), 1011-1012, 2020 | 89 | 2020 |
| Role of Combined [68Ga]Ga-DOTA-SST Analogues and [18F]FDG PET/CT in the Management of GEP-NENs: A Systematic Review L Carideo, D Prosperi, F Panzuto, L Magi, MS Pratesi, M Rinzivillo, ... Journal of clinical medicine 8 (7), 1032, 2019 | 81 | 2019 |
| Everolimus in pancreatic neuroendocrine carcinomas G3 F Panzuto, M Rinzivillo, F Spada, L Antonuzzo, T Ibrahim, D Campana, ... Pancreas 46 (3), 302-305, 2017 | 80 | 2017 |
| Somatostatin receptor subtypes: basic pharmacology and tissue distribution VD Corleto, S Nasoni, F Panzuto, S Cassetta, G Delle Fave Digestive and liver disease 36, S8-S16, 2004 | 77 | 2004 |
